Evidence map›Paper›PMID 39844883›Full record

ReviewToxicology reports2025

Harnessing machine learning in contemporary tobacco research.

Krishnendu Sinha, Nabanita Ghosh, Parames C Sil

Abstract readReview
In one paragraph

Review in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Krishnendu SinhaJhargram Raj College, Jhargram 721507, India.
Nabanita GhoshMaulana Azad College, Kolkata 700013, India.
Parames C SilDivision of Molecular Medicine, Bose Institute, Kolkata 700054, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Machine learning (ML) has the potential to transform tobacco research and address the urgent public health crisis posed by tobacco use. Despite the well-documented health risks, cessation rates remain low. ML techniques offer innovative solutions by analyzing vast datasets to uncover patterns in smoking behavior, genetic predispositions, and effective cessation strategies. ML can predict smoking-induced non-communicable diseases (SiNCDs) like lung cancer and postmenopausal osteoporosis by identifying biomarkers and genetic profiles, generating personalized predictions, and guiding interventions. It also improves prediction of infant tobacco smoke exposure, distinguishes secondhand and thirdhand smoke, and enhances protection strategies for children. Data-driven, personalized approaches using ML track real-time data for personalized feedback and offer timely interventions, continuously improving cessation strategies. Overall, ML provides sophisticated predictive models, enhances understanding of complex biological mechanisms, and enables personalized interventions, demonstrating significant potential in the fight against the tobacco epidemic.

Indexed as

AlgorithmsCancerMachine learningSmokingTobaccoVapes

Identifiers

PMID39844883
PMCPMC11750557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.